Gain Therapeutics, Inc.
GANX
$2.12
-$0.05-2.08%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -20.63% | 136.59% | 31.57% | -26.20% | -12.67% |
| Total Receivables | 23.91% | 1.79% | -44.24% | 59.51% | 15.77% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 15.26% | -35.22% | -23.12% | 0.30% | 164.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -18.06% | 111.43% | 13.01% | -16.54% | -3.89% |
|
|
|||||
| Total Current Assets | -18.06% | 111.43% | 13.01% | -16.54% | -3.89% |
| Net Property, Plant & Equipment | -13.20% | 51.48% | -18.03% | 17.14% | -13.02% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -12.45% | -10.30% | -10.40% | 1.27% | -5.96% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.29% | 0.29% | -0.29% | 7.36% | 2.19% |
| Total Assets | -17.88% | 107.98% | 11.57% | -15.40% | -4.12% |
|
|
|||||
| Total Accounts Payable | 83.81% | -47.69% | -41.87% | 26.10% | 127.35% |
| Total Accrued Expenses | -7.82% | -1.35% | 5.55% | -8.65% | -1.81% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.72% | -8.61% | -7.96% | 0.23% | -3.43% |
| Total Finance Division Other Current Liabilities | 54.76% | -25.17% | 20.25% | -79.69% | -12.89% |
| Total Other Current Liabilities | 54.76% | -25.17% | 20.25% | -79.69% | -12.89% |
| Total Current Liabilities | 15.93% | -19.62% | -19.75% | 3.35% | 28.56% |
|
|
|||||
| Total Current Liabilities | 15.93% | -19.62% | -19.75% | 3.35% | 28.56% |
| Long-Term Debt | -8.93% | 0.44% | -8.17% | 3.47% | -4.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.78% | 224.92% | -30.03% | 203.59% | -42.91% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -0.26% | -26.01% | 0.98% | 11.00% | -4.11% |
| Total Liabilities | 11.22% | -15.96% | -17.52% | 5.02% | 22.16% |
|
|
|||||
| Common Stock & APIC | 0.70% | 16.62% | 7.94% | 3.30% | 3.20% |
| Retained Earnings | -5.53% | -4.69% | -5.77% | -6.78% | -5.58% |
| Treasury Stock & Other | 28.33% | 37.94% | -3.58% | 587.16% | 51.56% |
| Total Common Equity | -24.55% | 214.16% | 59.88% | -36.05% | -21.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -24.55% | 214.16% | 59.88% | -36.05% | -21.25% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -24.55% | 214.16% | 59.88% | -36.05% | -21.25% |
|
|
|||||